Overview

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

Status:
Completed
Trial end date:
2017-04-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that the biliary concentration of TCR is a good marker of its immunosuppressive activity.
Details
Lead Sponsor:
Rennes University Hospital
Treatments:
Tacrolimus